Navigation Links
US Drug Watchdog Now Urges Family Members Of Diabetics Who Used the Diabetes Drug Actos and Then Were Diagnosed with Bladder Cancer to Call The Johnson Law Group ASAP
Date:1/30/2013

(PRWEB) January 30, 2013

The US Drug Watchdog is now saying, "It is almost impossible to comprehend that a very popular diabetes drug called Actos may be a contributing factor to the development of bladder cancer, but that is our fear. Even worse, with almost no publicity about this issue we believe there could be thousands of US citizens, who used Actos, developed bladder cancer, and possibly died without anyone ever making the connection between the bladder cancer, and the diabetes drug. Because of this we are now urging family members, friends, or loved ones of diabetics, who have been diagnosed with bladder cancer, to ask if they were also using the diabetes drug called Actos?" As a background, according to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension that became effective July 11, 2011." The US Drug Watchdog says, "We now believe bladder cancer, and diabetics using the diabetes drug called Actos is a much bigger issue than we ever dreamed possible, and are urging all Actos users who now have bladder cancer to contact the Johnson Law Group at 1-800-996-9900 for a legal evaluation. http://www.johnsonlawgroup.com/

The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims, or the family members of victims." http://USDrugWatchdog.Com

Case number 11cv2406 BEN BGS
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
2. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
3. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
4. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
5. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Know The Symptoms Of A Failure And Offers To Name The Best Lawyers & Law Firms For Failure Victims
6. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
7. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
8. US Drug Watchdog Now Offers To Help Women Who Used TheOsteoporosis Drug Called Fosamax And Then Had A Unexplainable Femur Fracture Get To The Best Attorneys Or Law Firms
9. The US Drug Watchdog Now Offers Women Who Had A Heart Attack Or Stroke After Using The Birth Control Pills Yaz Yasmin Birth Control Pills Get To The Best Attorneys
10. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
11. US Drug Watchdog Now Offers Victims of All Metal Hip Implant Failure the Names of the Best Attorneys & Calls Metal Hip Implants a Train Wreck with Up to 500,000 Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... NY (PRWEB) September 19, 2014 The ... the five years to 2014. Industry operators were able ... during the period, as well as establish distribution contracts ... due in large part to its novelty; energy drinks ... in that time, industry operators have been able to ...
(Date:9/19/2014)... 2013 NEXT Award-winning technology consultancy ... for the 2014 NEXT Awards in the Technology ... has been selected as the sole female finalist ... Chamber of Commerce and the Nashville Entrepreneur Center ... accomplishments of companies and individual entrepreneurs in five ...
(Date:9/19/2014)... San Jose, California (PRWEB) September 19, 2014 ... – Buoyed by technological advancements, surgical techniques, and ... become the preferred treatment for several chronic diseases ... liver. Advancements in organ and tissue transplantation have ... patients. Organ transplant today represents a ...
(Date:9/19/2014)... researchers at the University of Utah School of Medicine ... of mitochondria in debilitating and fatal motor neuron diseases ... such illnesses. , Researchers led ... when healthy, functioning mitochondria was prevented from moving along ... neurons mice developed symptoms of neurodegenerative diseases. In ...
(Date:9/19/2014)... grow well in infertile land, and bear many beans ... is because most legumes have a symbiotic relationship with ... air and then supply the host plant with ammonia ... organs called nodules in their roots. However, if too ... the growth of the plants, because the energy cost ...
Breaking Medicine News(10 mins):Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 2Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Mouse model sheds light on role of mitochondria in neurodegenerative diseases 2Health News:Mouse model sheds light on role of mitochondria in neurodegenerative diseases 3Health News:Long-distance communication from leaves to roots 2
... June 29 Medicsight PLC, a subsidiary of MGT Capital ... industry leader in the development of Computer-Aided Detection (CAD) and ... of disease, is pleased to announce the launch of its ... benefits of Medicsight,s ColonCAD software truly accessible to all radiologists ...
... , LONDON, June 29 The Healthcare Group at ... Quarterly Analyst Briefing Presentation on the European Hospital Information Systems ... at 2 p.m. GMT. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ... some kind of information system in place, only a few ...
... Clarient, Inc. (Nasdaq: ... services resource for pathologists, oncologists and the pharmaceutical industry, today announced ... Index when Russell Investments reconstitutes its comprehensive set of U.S. and ... of additions posted June 12 on www.russell.com . ...
... ... your pet healthy and happy and is more likely to avoid serious and costly health problems ... ... health care can prevent expensive vet bills in the future, pet owners are reminded, as everyone continues ...
... Florida,s First Certified Urgent ... County Florida has become the first in the State to receive formal recognition as a Certified ... ... Care Medical Centers of Palm Beach County Florida has become the first in the State to ...
... ... to access critical health data stored in electronic health records (EHRs). The company has just ... , ... 29, 2009 -- Orion Health , a market leader in providing clinical workflow and ...
Cached Medicine News:Health News:Medicsight Launches ColonCAD(TM) Online CTC Platform 2Health News:Medicsight Launches ColonCAD(TM) Online CTC Platform 3Health News:Hospital Information Systems (HIS) Markets in Europe: Frost & Sullivan Reveals the Cost, Crunch and the Care Value 2Health News:Clarient Set to Join Russell 3000 Index 2Health News:Clarient Set to Join Russell 3000 Index 3Health News:Clarient Set to Join Russell 3000 Index 4Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 2Health News:Proactive Pet Care Essential in Low Cash Times, Says NOAH 3Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth 2Health News:Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth 3
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... 2014 Intarcia Therapeutics, Inc. today ... its lead candidate ITCA 650 (continuous subcutaneous delivery of ... HbA1c levels at the 50 th Annual Meeting ... (EASD). Data from the open-label, phase 3 FREEDOM-HBL (high ... in patients with poorly controlled type 2 diabetes. The ...
(Date:9/18/2014)... DUBLIN , September 19, 2014 /PRNewswire/ ... and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced ... Cytogenetics Market 2014-2018" report to their ... ,Molecular Cytogenetics involves the study of chromosomes ... and functions of genes and chromosomes. It ...
Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... The Driver Stent design, ... surpasses the limitations of stainless ... makes possible thinner struts, for ... support. The Driver Coronary Stent ...
The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner....
The soft tip sheath design for smooth delivery and retrieval of Constellation advanced mapping basket catheters....
Fast-Cath, Maximum, Maximum Xtra, and Maximum ACT introducers represent the largest line of standard and specialty hemostasis introducers in the world....
Medicine Products: